Balance Sheet for NeuroBo Pharmaceuticals Inc. (NRBO)

$ 7.02   0.39 (+5.88%) Volume: 60.24k 4:00 PM EDT 10-Aug-2020
After Hours:  $ 6.73   -0.29 (-4.13%) Volume: 135 5:54 PM EDT 10-Aug-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 13,908 2,845 18,473 24,033 3,620
Restrictable Cash 15 - - - -
Marketable Securities - - - - -
Accounts Receivable - - - - -
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables - - - - -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 153 929 490 713 23
Current Deferred Income Taxes - - - - -
Other Current Assets 42 34 25 - -
Total Current Assets 14,118 3,808 19,009 24,746 3,643
Land and Improvements - - - - -
Buildings and Improvement - - - - -
Machinery, Furniture and Equipment 217 3 - - -
Construction in Progress - - - - -
Fixed Assets, Other 150 9 - - -
Fixed Assets, Total 367 12 - - -
Gross Fixed Assets 367 12 - - -
Accumulated Depreciation (17) - - - -
Net Fixed Assets 350 12 - - -
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - 5 10
Other Non-Current Assets - - - - -
Total Non-Current Assets 350 12 8 8 847
Total Assets 14,468 3,820 19,017 24,754 4,490
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 638 170 4,025 2,008 531
Short Term Debt 22 9,437 1,355 11,089 1,795
Notes Payable - - - - 4,629
Accrued Expenses 1,422 49 704 1,407 1,615
Accrued Liabilities 1,422 49 704 1,407 1,615
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities - (9,437) 306 (10,388) 337
Total Current Liabilities 2,082 219 6,390 4,121 8,917
Long Term Debt N/A 118 8,683 - -
Deferred Income Tax - - - - -
Other Non-Current Liabilities - - 3 1 -
Minority Interest - - - - -
Capital Lease Obligations 94 23 - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - 16,746 - - 7,953
Total Non-Current Liabilities 94 16,887 8,686 1 7,953
Total Liabilities 2,176 17,106 15,076 4,122 16,870
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 12,292 (13,286) 3,941 20,632 (12,380)
Common Par 16 - 18 17 12
Additional Paid in Capital 49,130 2,266 64,397 47,674 -
Cumulative Translation Adjustments - - - - -
Retained Earnings (36,866) (15,554) (60,474) (27,059) (12,392)
Treasury Stock - - - - -
Other Equity Adjustments 12 2 - - -
Total Capitalization 12,292 (13,168) 12,624 20,632 (12,380)
Total Equity 12,292 (13,286) 3,941 20,632 (12,380)
Total Liabilities & Shareholder's Equity 14,468 3,820 19,017 24,754 4,490
Cash Flow (19,975) (15,529) (33,415) (14,952) (11,997)
Working Capital 12,036 3,589 12,619 20,625 (5,274)
Free Cash Flow (7,253) (14,454) (26,901) (11,043) (5,433)
Invested Capital 12,292 (13,168) 12,624 20,632 (12,380)
Shares Outstanding - Common Class Only 15,593 571 425 9,270 -
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 15,593 571 425 9,270 9,182
Total Common Shares Outstanding 15,593 571 425 9,270 -
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 5,224 4,251 414 5,809 4,305
Diluted Weighted Shares Outstanding 5,224 4,251 414 5,809 4,305